04/21/2022 | Press release | Archived content
Published on Apr 21, 2022
DHP urges licensees of health regulatory boards to encourage patient participation, April 30, 2022, in DEA's Drug Take-Back Day. For more information read this open letter from DHP Director, Dr. David Brown and visit the National Prescription Drug Take Back Day web page.